Alicia Secor is Director at GW PHARMACEUTICALS PLC (GWPH). They have made 5 open-market trades across 3 companies since 2014, most recently 2024-09-18.
CIK 0001584516
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $109K since 2014, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GWPH | SELL | 2020-03-02 | 2020-03-04 | $8.34 | $11K | -28.2% | -18.9% | +26.2% |
| GWPH | SELL | 2020-01-03 | 2020-01-07 | $8.53 | $13K | +16.7% | +16.0% | -15.1% |
| GWPH | SELL | 2019-03-13 | 2019-04-12 | $14.20 | $13K | -3.2% | +3.1% | +4.0% |
| JNP | BUY | 2016-08-25 | 2016-08-29 | $5.75 | $29K | -1.7% | -0.7% | -2.6% |
| ZFGN | SELL · 10b5-1 | 2015-09-17 | 2015-09-21 | $41.05 | $1.1M | -0.3% | +1.3% | +1.3% |
| ZFGN | BUY | 2014-06-19 | 2014-06-23 | $20.00 | $80K | -0.3% | +1.3% | +1.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.